“I wish we had the chance to find out.” This poignant statement from Cindy Blewett encapsulates the tragic outcome of a healthcare system entangled in bureaucratic delays, a system that may have contributed to her husband Kenney’s suicide after a crucial medication was delayed due to insurance issues.
The story of Kenney Blewett, a man battling chronic obstructive pulmonary disease (COPD) exacerbated by decades of smoking, serves as a stark illustration of the life-or-death consequences of insurance complexities. His pulmonologist prescribed a new, potentially life-altering medication to manage severe breathing flare-ups that left him feeling as though he couldn’t breathe. However, what should have been a straightforward prescription fill turned into a Kafkaesque ordeal of delays and confusion, ultimately leading to a devastating loss. This incident casts a harsh spotlight on the widespread problem of insurance delays and denials in the American healthcare system, a burden that nearly 7 in 10 adults perceive as a "major problem," according to a January KFF Health Tracking Poll.
Kenney Blewett, a resident of Kyle, Texas, had been living with lung disease for over a decade. This year, however, the condition escalated, triggering increasingly frequent and terrifying flare-ups that made him feel on the brink of suffocation. Cindy Blewett described these episodes as "the scariest thing in the world," noting their growing frequency and the profound impact on Kenney’s daily life. Even simple tasks became arduous, leaving him breathless. His declining health was further evidenced by a significant weight loss of 45 pounds, a symptom one of his doctors noted could be indicative of cancer, underscoring the severity of his deteriorating condition, which was undeniably linked to his history of smoking.
On June 2, Kenney’s pulmonologist, Dr. Rajesh Shetty of LungDocs, prescribed a new medication specifically designed to alleviate his debilitating breathing issues. The hope was that this new treatment would offer him relief and a better quality of life. However, this hope was quickly overshadowed by administrative hurdles. Just two days after the appointment, the Blewetts received an email from Walgreens stating that the prescription was delayed due to an "insurance issue that we’re working to resolve." This delay proved to be a critical turning point.
"He was hopeful that it would work," Cindy recounted, two months after Kenney’s death, her voice heavy with grief. "I wish we had the chance to find out." The medication, a liquid to be inhaled via a nebulizer, was a crucial part of Kenney’s treatment plan. Its delayed arrival left him without the potential relief he desperately needed.
The incident involving Kenney Blewett is not an isolated one. Insurance delays and denials have become an "infamous feature of the American healthcare system." This issue has garnered national attention, prompting efforts to address it. In June 2025, following a high-profile incident involving the CEO of UnitedHealthcare, the Trump administration announced a widely publicized industry pledge, signed by numerous major health insurers, aimed at dismantling barriers that impede patient access to doctor-recommended care. This pledge sought to streamline prior authorization processes, a common requirement where insurers must approve treatments before they are administered. However, the voluntary nature of this pledge, lacking any enforcement mechanisms or penalties for non-compliance, has raised questions about its effectiveness. A subsequent report by KFF Health News in July revealed that some insurers who signed the pledge were not fully implementing the promised initiatives as initially outlined, suggesting that the commitment to reform may be superficial.
In the absence of substantial federal reform, lawmakers in many states, including Texas, have sought to regulate the insurance industry and mitigate delays and denials. However, these state-level regulations often do not extend to the majority of health insurance plans, such as traditional Medicare policies and employer-sponsored offerings, which collectively cover more than half of all Americans. This creates a complex and fragmented regulatory landscape that is challenging to navigate.
The intricacies of insurance regulations are so convoluted that even medical office staff and pharmacy employees often find them confusing. This problem is poised to become even more complicated with the increasing integration of artificial intelligence (AI) into the claims processing and approval systems. AI’s growing role in healthcare decision-making, while promising efficiency, also introduces new layers of complexity and potential for error, as highlighted by KFF Health News’s reporting on AI’s impact on prior authorization.
Matt Toresco, CEO of ArchÅ, a patient advocacy and consulting company, expressed the sentiment of many when he stated, "It’s just gotten completely out of hand." He emphasized the urgent need for greater patient support in navigating these pervasive insurance hurdles. The Blewett family’s experience vividly illustrates the "herculean task" patients and their caregivers face in deciphering these complex systems.
Cindy Blewett has been on a relentless quest for answers, reaching out to Medicare, Kenney’s private Part D drug plan, his pulmonologist’s office, and Walgreens. She remains uncertain about who bore responsibility for the medication delay and, more importantly, how such a preventable holdup could have occurred. The critical question lingering in her mind is whether Kenney would have made the agonizing decision to end his life on the evening of June 7, following his last severe COPD flare-up, if his prescribed medication had been available.
The confusion surrounding Kenney’s prescription stemmed from the intricate distinctions between Medicare Part B and Part D coverage. The prescribed medication, an inhaled liquid for a nebulizer, was one of the few medications covered under Medicare Part B’s durable medical equipment benefit, rather than Part D, which typically covers prescription drugs. This distinction, often misunderstood, became a significant roadblock.
Cindy’s initial assumption was that Kenney’s Part D plan had enacted a prior authorization requirement. However, the federal government had no record of the prescription being billed to his Part B policy. Representatives for Centene, the parent company of Wellcare Value Script, Kenney’s Part D provider, declined to comment on the specific case.
When Cindy followed up with Walgreens, she received conflicting information. Initially, she was told the prescription required prior authorization. Later, an employee explained that the prescription had been submitted to Medicare Part B but lacked a necessary diagnostic code, which should have been included by the physician. Walgreens spokesperson Carmen Lopez stated that the company "cannot comment on matters involving specific individuals."
Subsequently, a Walgreens district pharmacy supervisor contacted Cindy, explaining that the pharmacy had attempted to process the prescription through Part B on June 2 but discovered the missing diagnostic code. The supervisor claimed Walgreens had sent a request for this code to the pulmonologist’s office the same day. However, an employee at Dr. Shetty’s practice informed Cindy that they had not received any fax from Walgreens requesting a diagnostic code. This communication breakdown between the pharmacy and the physician’s office created a frustrating impasse. Furthermore, Kenney’s Medigap plan, which covered other out-of-pocket expenses, would not have required prior authorization, as these policies are not subject to such stipulations. "Short of getting attorneys involved," Cindy lamented, "I’m not sure how to find out what really happened."
The complexities of Medicare, particularly the differences between Part B and Part D, are a common source of confusion, according to Mike Hess, senior director of patient outreach and education at the COPD Foundation. He noted that the Medicare system has become "so complex and convoluted over the years" that even healthcare professionals struggle to grasp its nuances.
The growing reliance on AI in the preapproval process is anticipated to further complicate matters for Medicare beneficiaries and their physicians. While traditional Medicare has historically used prior authorization sparingly, a pilot program launched in January in six states (Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington) is now testing the use of AI for preapproving certain healthcare services. The Centers for Medicare & Medicaid Services (CMS) Administrator, Mehmet Oz, stated the program’s intention is to "root out waste in Original Medicare." However, physicians and patients have voiced concerns that this AI-driven system is generating more bureaucratic red tape and leading to inappropriate denials. While COPD medications are not currently subject to prior authorization within this pilot, industry experts foresee an expansion of the program’s scope.
On the tragic night of June 7, hours after Kenney’s final, agonizing COPD flare-up, Cindy was on their back porch when she heard a gunshot. She initially dismissed it as an object falling inside their home, only to discover Kenney’s body in their bedroom. "I can’t tell you how horrible it was," she stated, her voice trembling.
Cindy revealed that Kenney had a long history of mental health struggles and had previously attempted suicide years prior. His deteriorating physical health, she believes, exacerbated his mental anguish. Kenney’s final words, left in a note, confirmed this sentiment. He expressed his deep love for Cindy, their children, and grandchildren but stated that his health had become too unbearable to continue living.
Adding to the tragedy, a second COPD medication, which Dr. Shetty had ordered directly from the manufacturer during the June 2 appointment, arrived several weeks after Kenney’s death. "Perhaps, just perhaps," Cindy mused through her tears, "if he had received both medications in a timely manner, he would be here today, and we would have had many more years together." Her words echo the profound sense of loss and the unanswerable "what ifs" that plague families caught in the labyrinth of the American healthcare system.
